Inventor · disambiguated record
Gerardo Castillo
Also filed as: CASTILLO GERARDO · CASTILLO GERARDO M · SNOW ALAN D
53 granted patents·29 pending applications·559 citations·filing 1998–2024
98Inventor score
Top patents by PatentIndex Score
82 records- 0196US7635463B2Compositions for delivery of therapeutics and other materialsPHARMAIN CORP·Filed 2007·Granted Dec 22, 2009·36 cites·18 claims
- 0295US8257682B2Compositions for delivery of therapeutics and other materialsBOLOTIN ELIJAH M·Filed 2009·Granted Sep 4, 2012·30 cites·19 claims
- 0395US8231859B2Compositions for delivery of therapeutics and other materialsBOLOTIN ELIJAH M·Filed 2009·Granted Jul 31, 2012·30 cites·13 claims
- 0494US8277776B2Compositions for delivery of therapeutics and other materialsBOLOTIN ELIJAH M·Filed 2009·Granted Oct 2, 2012·26 cites·22 claims
- 0594US7763747B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's diseasePROTEOTECH INC·Filed 2008·Granted Jul 27, 2010·21 cites·21 claims
- 0694US7285293B2Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plantsCASTILLO GERARDO·Filed 2003·Granted Oct 23, 2007·87 cites·25 claims
- 0793US7960336B2Composition for long-acting peptide analogsPHARMAIN CORP·Filed 2008·Granted Jun 14, 2011·25 cites·20 claims
- 0889US6607758B2Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidosesUNIV WASHINGTON·Filed 2001·Granted Aug 19, 2003·23 cites·19 claims
- 0988US7514583B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's diseasePROTEOTECH INC·Filed 2003·Granted Apr 7, 2009·22 cites·22 claims
- 1087US8003612B2Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disordersPROTEOTECH INC·Filed 2008·Granted Aug 23, 2011·4 cites·19 claims
- 1187US7601876B2Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosisPROTEOTECH INC·Filed 2007·Granted Oct 13, 2009·8 cites·36 claims
- 1287US6933280B2Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersFiled 2001·Granted Aug 23, 2005·13 cites·4 claims
- 1384US7759311B2Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersPROTEOTECH INC·Filed 2007·Granted Jul 20, 2010·2 cites·3 claims
- 1484US6037327ASpecific saccharide compositions and methods for treating Alzheimer's disease and other amyloidosesUNIV WASHINGTON·Filed 1998·Granted Mar 14, 2000·57 cites·4 claims
- 1583US7229968B2Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersUNIV WASHINGTON·Filed 2004·Granted Jun 12, 2007·4 cites·4 claims
- 1683US7208475B2Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersUNIV WASHINGTON·Filed 2004·Granted Apr 24, 2007·4 cites·4 claims
- 1780US9657078B2Composition for long-acting peptide analogsPHARMAIN CORP·Filed 2015·Granted May 23, 2017·2 cites·23 claims
- 1880US8563527B2Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the sameCASTILLO GERARDO M·Filed 2008·Granted Oct 22, 2013·3 cites·18 claims
- 1978US9090664B2Composition for long-acting peptide analogsPHARMAIN CORP·Filed 2013·Granted Jul 28, 2015·2 cites·37 claims
- 2078US8999930B2Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the sameCASTILLO GERARDO M·Filed 2010·Granted Apr 7, 2015·3 cites·27 claims
- 2178US7314724B2Therapeutic applications of laminin and laminin-derived protein fragmentsUNIV WASHINGTON·Filed 2001·Granted Jan 1, 2008·4 cites·4 claims
- 2278US7189698B2Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersUNIV WASHINGTON·Filed 2004·Granted Mar 13, 2007·2 cites·4 claims
- 2377US8518876B2Composition for long-acting peptide analogsCASTILLO GERARDO M·Filed 2011·Granted Aug 27, 2013·2 cites·20 claims
- 2477US7745490B2Substituted N-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathiesPROTEOTECH INC·Filed 2006·Granted Jun 29, 2010·2 cites·8 claims
- 2576US8163957B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's diseaseSNOW ALAN D·Filed 2010·Granted Apr 24, 2012·2 cites·22 claims
- 2676US7754250B2Composition and methods for treating Alzheimer's disease and other amyloidosesPROTEOTECH INC·Filed 2008·Granted Jul 13, 2010·1 cites·9 claims
- 2776US7384910B2Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersCASTILLO GERARDO M·Filed 2004·Granted Jun 10, 2008·11 cites·3 claims
- 2876US6264994B1Compositions for treating alzheimer's disease and other amyloidosesUNIV WASHINGTON·Filed 1998·Granted Jul 24, 2001·51 cites·18 claims
- 2975US7189699B2Peptides for the treatment of Alzheimer's disease and other β-amyloid protein fibrillogenesis disordersUNIV WASHINGTON·Filed 2004·Granted Mar 13, 2007·2 cites·4 claims
- 3075US6767898B2Methods for using specific saccharides for treating alzheimer's disease and other amyloidosesUNIV WASHINGTON·Filed 2002·Granted Jul 27, 2004·3 cites·7 claims
- 3174US8586585B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's diseaseSNOW ALAN D·Filed 2012·Granted Nov 19, 2013·1 cites·4 claims
- 3274US7276483B1Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disordersCASTILLO GERARDO M·Filed 2004·Granted Oct 2, 2007·4 cites·4 claims
- 3374US7148001B2In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseasesUNIV WASHINGTON·Filed 2001·Granted Dec 12, 2006·6 cites·10 claims
- 3473US6939570B1Composition and methods for treating Alzheimer's disease and other amyloidosesUNIV WASHINGTON·Filed 1998·Granted Sep 6, 2005·22 cites·14 claims
- 3572US10010613B2Anionic-core composition for delivery of therapeutic agents, and methods of making and using the sameCASTILLO GERARDO M·Filed 2010·Granted Jul 3, 2018·2 cites·16 claims
- 3672US9737615B2Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the samePHARMAIN CORP·Filed 2013·Granted Aug 22, 2017·1 cites·37 claims
- 3772US7314642B2Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plantsCASTILLO GERARDO·Filed 2003·Granted Jan 1, 2008·5 cites·20 claims
- 3872US7205008B2Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereofPROTEOTECH INC·Filed 2002·Granted Apr 17, 2007·2 cites·6 claims
- 3972US2008306143A1Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid DisordersCHOI PAULA·Filed 2008·Application pending·0 cites
- 4068US6929808B2Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plantsPROTEOTECH INC·Filed 2001·Granted Aug 16, 2005·5 cites·2 claims
- 4166US8895554B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's diseasePROTEOTECH INC·Filed 2013·Granted Nov 25, 2014·0 cites·19 claims
- 4266US7029710B2Methods of isolation of amyloid inhibitory ingredients within Uncaria tomentosaUNIV WASHINGTON·Filed 2003·Granted Apr 18, 2006·1 cites·28 claims
- 4366US6346280B1Composition and methods for inhibiting the formation of brain amyloid depositsUNIV WASHINGTON·Filed 1998·Granted Feb 12, 2002·26 cites·5 claims
- 4465US9051253B2Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson'sSNOW ALAN D·Filed 2013·Granted Jun 9, 2015·0 cites·5 claims
- 4565US2009197965A1Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's diseaseSNOW ALAN D·Filed 2008·Application pending·0 cites
- 4664US2020254100A1Anionic-core composition for delivery of therapeutic agents, and methods of making and using the samePHARMAIN CORP·Filed 2020·Application pending·0 cites
- 4763US12410211B2V1A receptor partial agonist and method of usePHARMAIN CORP·Filed 2021·Granted Sep 9, 2025·0 cites·25 claims
- 4863US10882961B2Method of production of graft co-polymer excipient with a superior peptide and protein binding propertyPHARMAIN CORP·Filed 2018·Granted Jan 5, 2021·0 cites·16 claims
- 4963US9133176B2Isolation, purification and synthesis of procyanidin B2 and uses thereofCASTILLO GERARDO·Filed 2008·Granted Sep 15, 2015·0 cites·9 claims
- 5063US7371731B2Methods for using glucose pentasulfate for treating amyloid associated with type II diabetesCASTILLO GERARDO·Filed 2004·Granted May 13, 2008·0 cites·7 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gerardo Castillo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →